FOSAPREPITANT DIMEGLUMINE
| Brand name | FOCINVEZ |
|---|---|
| Active ingredient | FOSAPREPITANT DIMEGLUMINE |
| Strength | EQ 150MG BASE/50ML (EQ 3MG BASE/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | August 2023 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 12042504 | January 2039 | product |
| 11065265 | January 2039 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.